For the first time in 4 weeks, the Non-penny Pot Stock Index (NPSI) decreased (-3.2%) after having increased 4.6%, 2.5% and 13.1% in each of the previous 3 weeks.

The NPSI tracks the 35 cannabis stocks that trade for US$1/share or more (i.e. 12% of the universe of 298 companies) and the performance of the index's constituents are presented below as well as that of the sector's 9 categories to allow for performance comparisons:

11 Non-penny Cannabis Stocks Advanced 

• 1 stock went UP in excess of 10% 
  • Greenlane (GNLN) +28.9%
• 2 stocks went UP between 5% and 9.9%
  • AYR (AYRSF) +8.9%
  • Abacus (ABAHF) +6.8%
• 8 stocks went UP between 0.2% and 4.9%

1 Non-penny Cannabis Stock had No Change in price

23 Non-Penny Cannabis Stocks Declined

• 7 stocks went DOWN more than 10%
  1. MediPharm (MEDIF) -29.7%
  2. New Age (NBEV) -15.7%
  3. Cresco (CRLBF) -15.5%
  4. Akerna (KERN) -11.5%
  5. Neptune (NEPT) -10.7%
  6. Planet 13 (PLNHF) -10.4%
  7. Tilray (TLRY) -10.3%
• 6 stocks went DOWN between 5% and 9.9%
  1. Cronos (CRON) -9.0%
  2. Acreage (ACRGF) -8.7%
  3. Zynerba (ZYNE) -8.5%
  4. Medicine Man (SHWZ) -7.0%
  5. GW Pharma (GWPH) -5.9%
  6. Organigram (OGI) -5.3%
• 10 stocks went DOWN between 0.5% and 4.9%

In addition, there are 2 high profile stocks that, while they trade below US$1/share (and, as such, are not eligible for inclusion in the NPSI), are worthy of mention, namely Aurora (ACB) -4.1% and Hexo (HEXO) +2.1%.

The NPSI has representation in 9 of the 11 industry sectors with the constituents of each based on their primary area of focus in the cannabis industry. Below are the number of NPSI constituents in each sector and their average price change during the week:

1. Cultivation & Retail Sector: 17 (-3.1%)
   • Sector consists of companies that grow and sell cannabis flower and related products.
2. Biotechnology Sector: 6 (-6.5%)
   • Sector consists of pharmaceutical companies focused on R&D of new drugs and products utilizing cannabinoids.
3. Marijuana-Infused Products Sector: 3 (-14.2%)
   • Sector consists of companies focused on developing and selling marijuana-infused products and companies focused on the extraction of cannabis compounds and their infusion into consumer products.
4. Consumption Devices Sector: 3 (+10.3%)
   • Sector consists of companies focused on developing and selling personal consumption devices for cannabis consumers such as vape pens and inhalers.
5. Agricultural Technology Sector: 2 (+0.9%)
   • Sector consists of companies focused on providing automated growing systems, greenhouses, farming products, nutrients, hydroponics, fertilization systems, horticultural expertise, LED/lighting technologies, air filtration systems, and climate control and energy efficiency systems.
6. Real Estate Sector: 1 (+1.3%)
   • Sector consists of investment companies and REITs that develop, own, and/or lease commercial real estate properties to licensed cannabis operators.
7. Business Services/Consulting Sector: 1 (-7.0%)
   • Sector consists of companies that provide professional services such as branding, packaging, bottling, compliance, physical security, transportation, lab testing, distribution, and insurance. consulting and other business services directly to marijuana cultivators and retailers.
8. Tech & Media Sector: 1 (-11.5%)
   • Sector covers companies that provide delivery services, enterprise software, e-commerce platforms, communication and mapping services, and trading platforms and companies that provide marijuana-related media including news, content, social networks, games, and entertainment.
9. Hemp Products Sector: 1 (+2.4%)
   • Sector consists of companies that produce and sell hemp products.
10. Investing & Media Sector: 0
    • Sector consists primarily of companies that own and/or manage a portfolio of cannabis assets and financial service providers that offer capital and financing solutions for companies in the cannabis industry.
11. Other/Ancillary Sector: 0
    • Sector consists of companies that provide products and services related to the broader cannabis economy that do not fit within the other sectors such as companies focused on developing breathalyzers and testing kits for marijuana consumers and organizations, cannabis vending machine manufacturers and cannabis medical clinics, hospitality and tourism companies.

Further details regarding the constituents of the new NPSI are as follows:

1. Price Range/Share

• 2 pot stocks that trade above US$20/share,
• 3 that trade between US$10 and US$20/share,
• 6 that trade between US$5 and US$10/share and
• 24 that trade between US$1 and US$5/share. (The official definition of a "penny" stock is one that trades below US$5/share but, when it comes to pot stocks, that is where almost all of them trade, so the more literal definition of stocks that trade for less than US$1/share is used.)

2. Market Cap/Constituent

• Large-Cap (+US$10B): 0
• Mid-Cap (US$2B to US$10B): 3
• Small-Cap (US$300M to US$2B): 11
• Micro-Cap (US$50M to US$300M): 17
• Nano-Cap (Less than US$50M): 4

To see how the above stocks, and the others that make up the balance of the new Non-penny Pot Stock Index (NPSI), have done on a daily basis over the last few months, visit my daily articles here.